Position in IDXX
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$5,981,318
New position
Shares Held
10,645
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 77.68905589478628.ToString("F0")%
Shared 0.ToString("F0")%
None 22.310944105213714.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Boston Trust Walden Corp holds $272,827,315 across 10 Diagnostics & Research names. IDXX ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
140,610 | $67,519,515 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
41,696 | $52,586,995 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
285,425 | $49,235,812 | |
| 4 | WAT |
Waters Corp /De/
|
105,541 | $31,430,109 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
59,772 | $29,379,730 | |
| 6 | A |
Agilent Technologies, Inc.
|
193,437 | $22,047,949 | |
| 7 | DHR |
Danaher Corp /De/
|
43,495 | $8,246,652 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
This page
|
10,645 | $5,981,318 |
All Filings in IDXX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,981,318 | 10,645 | Shares | Defined | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||